In 2007, it was the combined strength of the strength of the pharmaceutical company, the power of the product, and the conviction and enthusiasm of the developer that made it possible to ask the world about a drug that “improved” melasma for the first time in Japan. Then, in 2014, seven years after its launch, we continued to research stain care in response to customer feedback. The “Transino Brand” has evolved into a total care series for not only melasma but also blemishes. In order to support the beauty of busy people, we will deliver the behind-the-scenes story behind the development of the “Transino Brand”, which has cleared many hurdles.